Advance Nanotech announces financing for disease detection device

Oct. 4, 2005 – Advance Nanotech Inc. (OTC.BB:AVNA), a provider of financing and support services to drive the commercialization of nanotechnology discoveries, announced financing for BiMAT.

BiMAT is developing integrated, low cost and disposable sensors and sensor arrays for point of care diagnostics, clinical monitoring and biomolecular research. BiMAT sensors will incorporate thin film polysilicon transistors deposited on lightweight, inexpensive substrates. Two patent filings cover the sensor detection mechanism and a special thin film transistor (TFT) structure that enables integration and separate optimization of the electronic and sensor functions.

One of the key applications for the BiMAT technology will be to enable first responders – medics, EMTs and doctors – to analyze microscopic amounts biological material for specific diseases on site. The company says the technology could eliminate the need to send samples to specialized laboratories, speeding treatment and reducing problems of handling, storage, mislabeling and treatment delay.

The investment in BiMAT was made in partnership with The Center for Advanced Photonics and Electronics (CAPE) at the University of Cambridge in the UK. The amount of the financing was not disclosed.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.